Skip to main content
Clinical Trials/IRCT20190819044559N1
IRCT20190819044559N1CompletedPhase 1

Comparing the preoperative analgesia effects of oral Magnesium oxide and Naproxen for hysterectomy surgery in Afzalipour hospital , Kerman, 2019

Kerman University of Medical Sciences0 sites64 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
64

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 65 years (—)
Sex
Female

Inclusion Criteria

  • No history of sensitivity to magnesium and naproxen
  • Lack of liver diseases
  • No kidney or cardiovascular dysfunction
  • no lactation
  • age between 35 to 65

Exclusion Criteria

  • drug or opiod addiction
  • neurological disorder, pain or abuse of opiod analgesic
  • Concomitant treatment with analgesics or anti-inflammatory drugs
  • Chronic treatment with magnesium or calcium channel blockers
  • Patients with complicated appendectomy

Investigators

Similar Trials